Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Ltd has informed BSE that its Board of Directors will meet on Thursday, 12th February 2026. The key item on the agenda is to consider and approve the Unaudited Financial Results for the quarter ended 31st December 2025 (Q3 FY26), along with the Limited Review Report from the statutory auditors. The notice also includes a standard clause allowing any other business to be transacted with the Chair's permission. The filing is signed by Haresh Kapurlal Mehta, Chairman & Whole-Time Director, and was submitted to both BSE and NSE on 7th February 2026.
This is a routine regulatory intimation and does not, by itself, have a direct impact on the stock price. Investors should watch for the actual Q3 FY26 results on 12th February 2026, as the financial performance could influence short-term price movement.